Point-of-care testing for respiratory viruses in adults: The current landscape and future potential

scientific article published on 26 July 2015

Point-of-care testing for respiratory viruses in adults: The current landscape and future potential is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JINF.2015.07.008
P932PMC publication ID7172689
P698PubMed publication ID26215335

P50authorNathan J BrendishQ47576789
P2093author name stringTristan W Clark
Hannah F Schiff
P2860cites workEtiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods.Q51794340
Respiratory viruses in adults with community-acquired pneumonia.Q54433970
AdenovirusQ57097742
Disease burden of the most commonly detected respiratory viruses in hospitalized patients calculated using the disability adjusted life year (DALY) modelQ57769566
Routine antibiotics in hospital management of acute asthmaQ72521855
Effect of rapid diagnosis on management of influenza A infectionsQ73715950
Respiratory syncytial virus infection in adultsQ84804676
Association of influenza vaccination with reduced risk of venous thromboembolismQ84993365
Clinical and economic burden of community-acquired pneumonia among adults in EuropeQ22242008
Rapid viral diagnosis for acute febrile respiratory illness in children in the Emergency DepartmentQ24193608
Antibiotics for acute bronchitisQ24198126
Impact of patient characteristics on the risk of influenza/ILI-related complicationsQ24805282
Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trialsQ28178690
Viral pneumoniaQ28307886
FilmArray, an automated nested multiplex PCR system for multi-pathogen detection: development and application to respiratory tract infectionQ28477580
The annual impact of seasonal influenza in the US: Measuring disease burden and costsQ29030744
Mortality associated with influenza and respiratory syncytial virus in the United StatesQ29615578
Influenza-associated hospitalizations in the United StatesQ29619463
The co-pathogenesis of influenza viruses with bacteria in the lung.Q30359731
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.Q30362392
Outcome of critically ill patients with influenza virus infection.Q30380019
Evaluation of the Xpert Flu A Panel nucleic acid amplification-based point-of-care test for influenza A virus detection and pandemic H1 subtypingQ30392110
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysisQ30408691
Accuracy of rapid influenza diagnostic tests: a meta-analysisQ30413585
Impact of seasonal and pandemic influenza on emergency department visits, 2003-2010, Ontario, CanadaQ30430972
The influence of oseltamivir treatment on the risk of stroke after influenza infectionQ33621263
A National Study of the Impact of Rapid Influenza Testing on Clinical Care in the Emergency Department.Q33676993
Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illnessQ33684340
Access to a polymerase chain reaction assay method targeting 13 respiratory viruses can reduce antibiotics: a randomised, controlled trialQ33882305
The common coldQ34169126
Cost-utility of rapid polymerase chain reaction-based influenza testing for high-risk emergency department patients.Q34171619
The economic burden of non-influenza-related viral respiratory tract infection in the United StatesQ34177410
Favipiravir (T-705), a novel viral RNA polymerase inhibitorQ34374652
Respiratory syncytial virus infection in elderly and high-risk adultsQ34414401
Respiratory illness caused by picornavirus infection: a review of clinical outcomesQ34450652
Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trialsQ34460803
The effect of inhaled IFN-β on worsening of asthma symptoms caused by viral infections. A randomized trialQ34480446
Epidemiology and clinical presentation of the four human parainfluenza virus typesQ34559960
Viral respiratory infections in elderly patients and patients with chronic obstructive pulmonary diseaseQ34602673
Mortality benefits of influenza vaccination in elderly people: an ongoing controversyQ34693675
Circulating influenza virus, climatic factors, and acute myocardial infarction: a time series study in England and Wales and Hong KongQ35000880
Evaluation of Alere i Influenza A&B for rapid detection of influenza viruses A and B.Q35035778
Evaluation of the Xpert Flu rapid PCR assay in high-risk emergency department patients.Q35036277
Severe community-acquired adenovirus pneumonia in an immunocompetent 44-year-old woman: a case report and review of the literatureQ35143811
Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- tQ35175985
Real-time PCR in the microbiology laboratoryQ35685789
Comparison of the Idaho Technology FilmArray system to real-time PCR for detection of respiratory pathogens in childrenQ35689135
Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitisQ36089717
Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adultsQ36154160
Community-acquired pneumonia requiring hospitalization among U.S. childrenQ36420016
Impact of rapid diagnosis on management of adults hospitalized with influenzaQ36715027
The future of antibiotics and resistanceQ36741884
Community study of role of viral infections in exacerbations of asthma in 9-11 year old childrenQ36903511
Detection of respiratory viruses by molecular methodsQ36943130
Clinical impact of human coronaviruses 229E and OC43 infection in diverse adult populationsQ37247481
Better tests, better care: improved diagnostics for infectious diseasesQ37287115
Evaluation of the BioFire FilmArray respiratory panel and the GenMark eSensor respiratory viral panel on lower respiratory tract specimens.Q37546601
Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic reviewQ37602840
Respiratory syncytial virus- and human metapneumovirus-associated emergency department and hospital burden in adultsQ37699518
Prevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: a systematic reviewQ37736623
Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review.Q37810606
Respiratory syncytial virus infection in adult populationsQ37984109
The burden of influenza complications in different high-risk groups: a targeted literature reviewQ38061648
Impact of the availability of an influenza virus rapid antigen test on diagnostic decision making in a pediatric emergency departmentQ38110113
Point-of-care tests for infection control: should rapid testing be in the laboratory or at the front line?Q38126732
Respiratory syncytial virus: current and emerging treatment optionsQ38210541
Retrospective and prospective verification of the Cepheid Xpert influenza virus assayQ38284889
Influenza, influenza-like symptoms and their association with cardiovascular risks: a systematic review and meta-analysis of observational studies.Q38458413
Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United KingdomQ38494697
Beyond malaria--causes of fever in outpatient Tanzanian childrenQ38958988
Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trialQ39656655
Comparison of the FilmArray Respiratory Panel and Prodesse real-time PCR assays for detection of respiratory pathogensQ39664907
Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trialQ40152886
Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trialQ40206357
Identification of respiratory viruses with a novel point-of-care multianalyte antigen detection test in children with acute respiratory tract infectionQ40254579
Head-to-head comparison of the diagnostic accuracies of BD Veritor™ System RSV and Quidel® Sofia® RSV FIA systems for respiratory syncytial virus (RSV) diagnosisQ40263192
Effect of point-of-care influenza testing on management of febrile children.Q40465733
Accuracy and impact of a point-of-care rapid influenza test in young children with respiratory illnesses.Q40475279
Comparison of the Biofire FilmArray RP, Genmark eSensor RVP, Luminex xTAG RVPv1, and Luminex xTAG RVP fast multiplex assays for detection of respiratory virusesQ40521205
Economic analysis of rapid and sensitive polymerase chain reaction testing in the emergency department for influenza infections in childrenQ41231661
Diagnostic performance of near-patient testing for influenzaQ41244476
Prospective and retrospective evaluation of the Cepheid Xpert® Flu/RSV XC assay for rapid detection of influenza A, influenza B, and respiratory syncytial virusQ41495869
Influenza: the rational use of oseltamivirQ41510670
Efficacy and safety of treatment with an anti-m2e monoclonal antibody in experimental human influenzaQ41716512
Comparison of three commercial RT-PCR systems for the detection of respiratory virusesQ41756807
Direct Detection of Influenza A and B Viruses in Less Than 20 Minutes Using a Commercially Available Rapid PCR AssayQ42145065
Impact of a rapid respiratory panel test on patient outcomesQ42198245
Oral GS-5806 activity in a respiratory syncytial virus challenge study.Q42198937
Adults hospitalised with acute respiratory illness rarely have detectable bacteria in the absence of COPD or pneumonia; viral infection predominates in a large prospective UK sample.Q42200923
Multicenter clinical evaluation of the novel Alere™ i Influenza A&B isothermal nucleic acid amplification testQ42209475
Multiplex viral polymerase chain reaction testing using the FilmArray device compared with direct fluorescent antibody testingQ42225578
Performance of a rapid multi-analyte 2-photon excitation assay in children with acute respiratory infectionQ42229478
Human rhinovirus infection during naturally occurring COPD exacerbationsQ42231605
Incidence and characteristics of viral community-acquired pneumonia in adults.Q43708189
Vaccination coverage rates in eleven European countries during two consecutive influenza seasons.Q44308387
Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens, and presentationQ44917627
Evaluation of Sofia fluorescent immunoassay analyzer for influenza A/B virusQ45355674
Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly personsQ45356630
Rapid testing for respiratory syncytial virus in a paediatric emergency department: benefits for infection control and bed management.Q45369493
A role for Streptococcus pneumoniae in virus-associated pneumoniaQ45615871
Lack of sensitivity of rapid antigen tests for the diagnosis of respiratory syncytial virus infection in adultsQ45721944
Adult hospitalizations for laboratory-positive influenza during the 2005-2006 through 2007-2008 seasons in the United StatesQ45747055
Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trialQ46852230
Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reactionQ47766508
P433issue5
P407language of work or nameEnglishQ1860
P304page(s)501-510
P577publication date2015-07-26
P1433published inJournal of InfectionQ6295344
P1476titlePoint-of-care testing for respiratory viruses in adults: The current landscape and future potential
P478volume71